PJP — Invesco Pharmaceuticals ETF price, holdings and performance
Invesco Pharmaceuticals ETFInvesco Pharmaceuticals ETF (AMEX: PJP) is an exchange-traded fund. QuoTrend tracks its price, holdings, performance, fund flows and news.
Latest market price
125.16
+0.31+0.24%
TA
Loading chart...
Fund Snapshot
| Category | - | Asset Type | Equity | Tags | healthcare | Return% 1Y | 49.93% | Total Holdings | 29 | Perf Week | 2.81% |
| Sponsor | Invesco | ETF Type | Tags | sector | Return% 3Y | 18.02% | AUM | $498.20M | Perf Month | 3.65% | |
| Fund Family | Bond Type | Tags | - | Return% 5Y | 10.01% | NAV/sh | Perf Quarter | 16.78% | |||
| Index | - | Average Maturity | Tags | - | Return% 10Y | 52W High | 126.28 -0.89% | Perf Half Y | 15.71% | ||
| Index Weighting | Commodity Type | Tags | - | Return% SI | 52W Low | 83.16 50.49% | Perf YTD | 19.43% | |||
| Active/Passive | Quant Type | Tags | - | Flows% 1M | -1.93% | Volatility | 1.26% 1.40% | Perf Year | 50.15% | ||
| Dividend TTM | 1.06 (0.85%) | ESG Type | Tags | - | Flows% 3M | -5.50% | ATR (14) | 1.86 | Perf 3Y | 61.22% | |
| Dividend Ex-Date | Jun 22, 2026 | Dividend Type | Sector/Theme | Flows% YTD | -5.64% | RSI (14) | 66.33 | Perf 5Y | 53.83% | ||
| Dividend Gr. 3/5Y | - | Structure Type | Region | Flows% 1Y | Beta | 0.45 | Perf 10Y | 84.01% | |||
| Expense | 0.57% | Growth/Value | SMA20 | 3.40% | Flows% 3Y | Rel Volume | 0.61 | Prev Close | 124.85 | ||
| Inverse/Leveraged | Market Cap | SMA50 | 6.86% | Flows% 5Y | Avg Volume | 31.08K | Price | 125.16 | |||
| IPO Date | Jun 23, 2005 | Option/Short | Yes / Yes | SMA200 | 15.99% | 52W Range % | 97% | Volume | 19,052 | Change | 0.24% |
Assets Under Management
● Assets Under Management
Latest News
Aug-07-26
01:15AM
Jul-30-26
Jul-28-26
Jul-24-26
Jul-22-26
Jul-22-2603:13PM
12:32AM
Jul-20-26
Jul-20-2610:17AM
06:39AM
Jul-17-26
Jul-10-26
Jul-09-26
Jul-09-2602:47PM
Jul-08-26
Jul-08-2606:04PM
Jul-05-26
Fund
The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index. The underlying index is composed of common stocks of 30 U.S. pharmaceutical companies. These companies are engaged principally in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types. The fund is non-diversified.
Ownership
Per-holder 13F data isn't yet ingested for ETFs — coming with the next data layer expansion. Aggregate ownership shown above.